Homepage Featured News

December 20, 2024

COTA and Guardant Partner to Advance Precision Oncology Research and Therapy Development…

December 9, 2024

The 50 greatest innovations of 2024: Shield Blood Test

Blood tests for cancer are here and Guardant Health is leading the charge

October 30, 2024

TIME’s Best Inventions of 2024: Shield Blood Test

September 11, 2024

Opinion | Science Finds New Ways to Detect Cancer, but Politics Gets in the Way

July 16, 2024

It’s Time for a New Option in Colorectal Cancer Screening

May 30, 2024

TIME100 Most Influential Companies 2024: Guardant Health

May 13, 2024

Guardant Health Preps for FDA Advisory Panel Review of its Blood-Based Colorectal Cancer Screening Test

March 19, 2024

Meet the Diagnostics Company Helping Find Cancer and Choose the Right Treatment

July 5, 2023

Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan

Reimbursement supports expanded access to blood-based comprehensive genomic profiling with Guardant360 CDx for patients with advanced solid tumor cancers and their care teams across Japan